# Long Term Effects of Raloxifene Treatment on Bone Quality

> **NCT00532428** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 31 (actual)

## Conditions studied

- Osteoporosis, Post-Menopausal

## Interventions

- **DRUG:** Raloxifene
- **DRUG:** Raloxifene
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00532428
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2007-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532428, "Long Term Effects of Raloxifene Treatment on Bone Quality". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00532428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*